IT’S ONE OF THE SIDE EFFECTS OF THIS DIABETES TREATMENT
Nearly half of adults in the U.S. are interested in losing weight, leading many to explore medications that may support their goals. One option that has gained attention is Farxiga (dapagliflozin), a medication primarily used to treat Type 2 diabetes that can also result in weight loss.
Farxiga helps manage blood sugar by causing excess glucose to leave the body through urine. The medication also has other established benefits, including lowering the risk of hospitalization for heart failure and helping slow the progression of chronic kidney disease in certain patients.
However, using Farxiga off-label specifically for weight loss isn’t appropriate for everyone. Understanding how the medication works, how much weight loss may occur, and its potential risks can help determine whether it’s a suitable option to discuss with a healthcare provider.
Key Takeaways
- Farxiga can cause weight loss, although the FDA has not approved it specifically as a weight-loss medication. People taking it may lose an average of about 3 to 10 pounds.
- Farxiga works partly by helping the body remove excess glucose through urine, which can contribute to weight loss.
- Some people may begin noticing changes in their weight within about three days to four weeks after starting treatment.
- Farxiga is not appropriate for everyone. People with Type 1 diabetes or a history of diabetic ketoacidosis, genital yeast infections, or urinary tract infections should discuss these risks carefully with their healthcare provider.
Does Farxiga Cause Weight Loss?
arxiga (dapagliflozin) can cause weight loss, but the FDA has not approved it specifically as a weight-loss medication. Its approved uses include treating Type 2 diabetes, helping reduce the risk of heart failure, and slowing the progression of chronic kidney disease.
Because weight loss can occur while taking Farxiga, some healthcare providers use it off-label for weight management. Clinical research has found that people taking the medication for about 24 weeks lost up to around 7 pounds, while another study involving people with Type 2 diabetes and heart disease reported an average loss of approximately 6 pounds after one year.
The weight reduction is largely related to how Farxiga affects glucose and fluid levels. The medication causes additional glucose to leave the body through urine, meaning some calories are eliminated rather than being retained by the body. Increased urination can also reduce fluid volume, contributing to an initial drop in weight.
Overall, experts cited in the source estimate that people may lose approximately 3 to 10 pounds while taking Farxiga, although individual results vary.
How Does Farxiga Work for Weight Loss?
Farxiga belongs to a group of medications called SGLT2 inhibitors. These drugs are used for conditions including Type 2 diabetes, heart failure, and chronic kidney disease.
Dapagliflozin blocks the SGLT2 protein in the kidneys, preventing the kidneys from reabsorbing as much glucose back into the bloodstream. Instead, excess glucose is eliminated through urine.
This process can contribute to weight reduction because calories contained in the glucose are also lost through urine. The increased loss of fluid from urination can contribute to the initial decrease in body weight as well.
How Quickly Does Farxiga Cause Weight Loss?
Weight changes can begin relatively quickly after starting Farxiga.
Some research found that participants experienced a reduction in body weight within about three days. However, early weight loss is often primarily related to fluid loss rather than fat loss.
A typical timeline may look like this:
- First few days: Weight may begin falling as increased urination causes fluid loss.
- First 2–4 weeks: A noticeable reduction in body weight may occur, with much of the early change attributed to water loss.
- Around 6 weeks: Fat loss may become more apparent.
Weight can consist of fat, muscle, water, and other components. Water weight can change relatively quickly, while fat loss generally occurs more gradually.
Who Should Not Take Farxiga?
Although Farxiga may provide benefits for certain people with Type 2 diabetes, heart failure, or chronic kidney disease, it isn’t appropriate for everyone.
The source identifies the following situations as reasons to avoid or carefully consider Farxiga:
- Type 1 diabetes
- Genital yeast infections
- Urinary tract infections
- Chronic kidney disease requiring dialysis
- Previous bariatric surgery, including gastric bypass or sleeve gastrectomy
Farxiga can also increase the risk of diabetic ketoacidosis (DKA), a potentially life-threatening condition involving elevated ketones and insufficient insulin.
Extra caution may be necessary when Farxiga is used alongside medications such as:
- Diuretics, including hydrochlorothiazide
- Sulfonylureas and other glucose-lowering medications
- Lithium
Possible Side Effects of Farxiga
In addition to weight loss, possible side effects include:
- Dehydration
- Urinary tract infections
- Low blood sugar
- Bacterial infections
- Yeast infections
- Constipation
- Nausea
- Back pain
Because Farxiga increases glucose and fluid loss through urination, maintaining appropriate hydration and monitoring for adverse effects are important.
Is Farxiga a Good Long-Term Weight-Loss Medication?
According to the source, Farxiga isn’t recommended as a long-term weight-management treatment. Although weight loss can occur, the medication is primarily intended for its approved medical indications rather than as a dedicated weight-loss drug.
Other medications may be considered for people whose primary goal is weight management, including certain GLP-1 medications such as Wegovy (semaglutide) or Saxenda (liraglutide).
The appropriate choice depends on your health history, current medications, and treatment goals, so it’s important to discuss weight-management options with a healthcare provider.
The Bottom Line
Farxiga can lead to weight loss, but it isn’t FDA-approved specifically for that purpose. Research suggests that weight loss may be relatively modest, with some studies reporting approximately 6–7 pounds over several months to a year.
Weight changes may begin within the first few days, although early losses are often related to fluid rather than body fat. If you’re considering Farxiga for weight management, talk with a healthcare professional about whether it’s appropriate for your specific health needs and whether another treatment may be more suitable.
Source: SingleCare